Physician profile
James A Ewry
NPI 1477552339
$3,498.18
in general payments reported to CMS, 2019-2025
37 companies · $504 in 2025
The $504 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $367 · 2020: $392 · 2021: $440 · 2022: $498 · 2023: $597 · 2024: $700 · 2025: $504.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,801.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,801.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $462.80 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Pfizer INC. | $395.54 | 2019-2025 | |
| Abbvie INC. | $292.13 | 2021-2024 | |
| Lilly USA, LLC | $201.40 | 2021-2025 | Zepbound, Mounjaro, Jardiance |
| Astrazeneca Pharmaceuticals LP | $194.67 | 2019-2025 | Farxiga, Airsupra |
| Glaxosmithkline, LLC. | $192.61 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Otsuka America Pharmaceutical, INC. | $180.41 | 2022-2025 | Rexulti |
| Janssen Pharmaceuticals, INC | $159.76 | 2019-2022 | |
| Amarin Pharma, INC. | $126.09 | 2019-2021 | |
| Amgen INC. | $125.40 | 2020-2024 | Evenity, Prolia |
| Merck Sharp & Dohme LLC | $113.51 | 2019-2021 | |
| Exact Sciences Corporation | $106.13 | 2023-2025 | Cologuard Collection Kit |
| Kowa Pharmaceuticals America, INC. | $101.54 | 2019-2021 | |
| Abbott Laboratories | $87.46 | 2019-2024 | Freestyle Libre 3 |
| Astellas Pharma US INC | $71.66 | 2023-2024 | Veozah, Myrbetriq |
Show all 37 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Ewry listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.